Skip to content

Proguanil

Antimalarial — ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS

Also known as: chloroguanide, chloroguanide HCl, chloroguanide hydrochloride, proguanil HCl, proguanil hydrochloride

OfpFDA approvedATC P01BB01ATC P01BB51ATC P01BB52

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Proguanil is an ofp drug in the Antimalarial class catalogued in DrugCentral. It was first approved by the FDA in 2000. Its mechanism of action is classified as Dihydrofolate Reductase Inhibitors. DrugCentral lists 4 molecular targets, including Taar1, Bifunctional dihydrofolate reductase-thymidylate synthase and Bifunctional dihydrofolate reductase-thymidylate synthase. Recorded indications include Chloroquine-Resistant Plasmodium Falciparum Malaria Prevention, Falciparum malaria and Plasmodium Falciparum Malaria Prevention.

  • Approval status: ofp (first approved 2000 by the FDA).
  • Drug class: Antimalarial.
  • Mechanism of action: Dihydrofolate Reductase Inhibitors.
  • Molecular targets: Taar1, Bifunctional dihydrofolate reductase-thymidylate synthase, Bifunctional dihydrofolate reductase-thymidylate synthase and Bifunctional dihydrofolate reductase-thymidylate synthase (4 listed in DrugCentral).
  • Indications: Chloroquine-Resistant Plasmodium Falciparum Malaria Prevention, Falciparum malaria and Plasmodium Falciparum Malaria Prevention.
  • ATC code: P01BB01 (Biguanides).
  • Molecular formula: C11H16ClN5; molecular weight 253.73 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (3)

  • Chloroquine-Resistant Plasmodium Falciparum Malaria Prevention
  • Falciparum malaria
  • Plasmodium Falciparum Malaria Prevention

Off-label uses (1)

  • Vivax malaria

Contraindications (8)

  • Acute nephropathy
  • Anemia due to enzyme deficiency
  • Chronic diarrhea
  • Disease of liver
  • Hepatic failure
  • Hyperglycemia
  • Malabsorption States
  • Vomiting

Mechanism & targets

Mechanism of action (MoA)Dihydrofolate Reductase Inhibitors
Established pharmacologic classAntimalarial

Molecular targets (4)

TargetGeneActionActivity
Trace amine-associated receptor 1Taar1unknownEC50 5.27
Bifunctional dihydrofolate reductase-thymidylate synthase—unknown—
Bifunctional dihydrofolate reductase-thymidylate synthase—unknown—
Bifunctional dihydrofolate reductase-thymidylate synthase—inhibitor—

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
2000-07-14FDA—GLAXOSMITHKLINE

ATC classification

ATC codeTherapeutic hierarchy
P01BB01ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS › ANTIPROTOZOALS › ANTIMALARIALS › Biguanides
P01BB51ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS › ANTIPROTOZOALS › ANTIMALARIALS › Biguanides
P01BB52ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS › ANTIPROTOZOALS › ANTIMALARIALS › Biguanides

Reported adverse-event signals

Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.

MedDRA termLLR
Malaria251.2
Hallucination59.7
Psychotic disorder59.0
Plasmodium falciparum infection55.2
Schizophrenia45.9
Abnormal dreams42.6
Hypomania37.8
Pyrexia37.2
Exposure during pregnancy37.0
Vomiting33.4
Total lung capacity increased33.3
Asthma-chronic obstructive pulmonary disease overlap syndrome31.0

Chemical structure

Molecular formulaC11H16ClN5
Molecular weight253.73 g/mol
CAS number500-92-5
InChIKeySSOLNOMRVKKSON-UHFFFAOYSA-N
PubChem CID6178111
CC(C)NC(=N)NC(=N)NC1=CC=C(Cl)C=C1

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Proguanil used for?

DrugCentral lists the following indications for Proguanil: Chloroquine-Resistant Plasmodium Falciparum Malaria Prevention, Falciparum malaria and Plasmodium Falciparum Malaria Prevention.

How does Proguanil work?

Proguanil is classified as Dihydrofolate Reductase Inhibitors; its molecular targets in DrugCentral include Taar1, Bifunctional dihydrofolate reductase-thymidylate synthase, Bifunctional dihydrofolate reductase-thymidylate synthase and Bifunctional dihydrofolate reductase-thymidylate synthase (inhibitor).

When was Proguanil first approved?

Proguanil was first approved by the FDA in 2000.

What drug class does Proguanil belong to?

Proguanil is in the Antimalarial class.

What is the chemical formula of Proguanil?

Proguanil has the molecular formula C11H16ClN5 and a molecular weight of 253.73 g/mol.

Browse: all drugs starting with P · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

StatusOFP
First approval2000-07-14
AgencyFDA
Targets4
Indications3
FormulaC11H16ClN5
DrugCentral ID2282
Interactive profile